253 related articles for article (PubMed ID: 20599712)
21. Runt-related transcription factor 3 expression in human oral squamous cell carcinomas; implication for tumor progression and prognosis.
Tanji Y; Osaki M; Nagahama Y; Kodani I; Ryoke K; Ito H
Oral Oncol; 2007 Jan; 43(1):88-94. PubMed ID: 16798064
[TBL] [Abstract][Full Text] [Related]
22. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.
Kataoka H; Miura Y; Joh T; Seno K; Tada T; Tamaoki T; Nakabayashi H; Kawaguchi M; Asai K; Kato T; Itoh M
Oncogene; 2001 Feb; 20(7):869-73. PubMed ID: 11314020
[TBL] [Abstract][Full Text] [Related]
23. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
24. RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers.
Ito K
J Cell Biochem; 2011 May; 112(5):1243-9. PubMed ID: 21465522
[TBL] [Abstract][Full Text] [Related]
25. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
26. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
28. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
29. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.
Lai KW; Koh KX; Loh M; Tada K; Subramaniam MM; Lim XY; Vaithilingam A; Salto-Tellez M; Iacopetta B; Ito Y; Soong R;
Eur J Cancer; 2010 May; 46(8):1456-63. PubMed ID: 20176475
[TBL] [Abstract][Full Text] [Related]
32. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
[TBL] [Abstract][Full Text] [Related]
33. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
34. ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21.
Russell MW; Soliman MA; Schriemer D; Riabowol K
Biochem Biophys Res Commun; 2008 Sep; 374(3):490-5. PubMed ID: 18655775
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
36. Aberrant gata-3 expression in human pancreatic cancer.
Gulbinas A; Berberat PO; Dambrauskas Z; Giese T; Giese N; Autschbach F; Kleeff J; Meuer S; Büchler MW; Friess H
J Histochem Cytochem; 2006 Feb; 54(2):161-9. PubMed ID: 16087702
[TBL] [Abstract][Full Text] [Related]
37. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
38. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
39. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.
Kang SH; Bang YJ; Jong HS; Seo JY; Kim NK; Kim SJ
Br J Cancer; 1999 Jun; 80(8):1144-9. PubMed ID: 10376964
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]